中商官网
研究报告
兰卫医学（301060）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 463000000.0000 | 111000000.0000 | 111000000.0000 | 84342100.0000 | 329000000.0000 | 199000000.0000 | 131000000.0000 |
| 2014 | 541000000.0000 | 87869600.0000 | 89281700.0000 | 70340300.0000 | 463000000.0000 | 262000000.0000 | 201000000.0000 |
| 2015 | 608000000.0000 | 104000000.0000 | 110000000.0000 | 82310800.0000 | 566000000.0000 | 263000000.0000 | 302000000.0000 |
| 2016 | 805000000.0000 | 81140000.0000 | 87317000.0000 | 60208200.0000 | 944000000.0000 | 332000000.0000 | 612000000.0000 |
| 2017 | 923000000.0000 | 7139100.0000 | 5564200.0000 | -20193600.0000 | 1330000000.0000 | 226000000.0000 | 1104000000.0000 |
| 2018 | 1053000000.0000 | 107000000.0000 | 106000000.0000 | 73934300.0000 | 1443000000.0000 | 262000000.0000 | 1181000000.0000 |
| 2019 | 1153000000.0000 | 131000000.0000 | 126000000.0000 | 94611200.0000 | 1399000000.0000 | 186000000.0000 | 1213000000.0000 |
| 2020 | 1238000000.0000 | 178000000.0000 | 162000000.0000 | 134000000.0000 | 1472000000.0000 | 224000000.0000 | 1247000000.0000 |
| 2021 | 1778000000.0000 | 319000000.0000 | 318000000.0000 | 262000000.0000 | 2105000000.0000 | 466000000.0000 | 1640000000.0000 |
| 2022 | 4199000000.0000 | 949000000.0000 | 904000000.0000 | 739000000.0000 | 3747000000.0000 | 1474000000.0000 | 2273000000.0000 |
| 2023 | 1674000000.0000 | -136000000.0000 | -153000000.0000 | -162000000.0000 | 2987000000.0000 | 1007000000.0000 | 1980000000.0000 |
| 2024 | 1742000000.0000 | -69307900.0000 | -103000000.0000 | -98590200.0000 | 2623000000.0000 | 803000000.0000 | 1820000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 23.97 | 23.97 | 33.74 | 98.0100 | 3.6300 | 3.60 | 1.41 |
| 2014 | 16.27 | 16.50 | 19.28 | 42.3800 | 3.7100 | 3.51 | 1.17 |
| 2015 | 16.94 | 18.09 | 19.43 | 32.0400 | 3.3500 | 2.64 | 1.07 |
| 2016 | 10.06 | 10.85 | 9.25 | 12.7200 | 4.5500 | 2.65 | 0.85 |
| 2017 | -0.98 | 0.60 | 0.42 | 0.5900 | 4.1300 | 2.66 | 0.69 |
| 2018 | 8.36 | 10.07 | 7.35 | 6.5800 | 3.9400 | 2.75 | 0.73 |
| 2019 | 9.19 | 10.93 | 9.01 | 7.9800 | 4.5800 | 2.73 | 0.82 |
| 2020 | 12.68 | 13.09 | 11.01 | 9.2100 | 5.2300 | 2.57 | 0.84 |
| 2021 | 16.48 | 17.89 | 15.11 | 15.0000 | 7.6700 | 2.71 | 0.84 |
| 2022 | 22.31 | 21.53 | 24.13 | 34.3900 | 8.9100 | 2.78 | 1.12 |
| 2023 | -10.10 | -9.14 | -5.12 | -7.3500 | 3.4500 | 1.04 | 0.56 |
| 2024 | -5.45 | -5.91 | -3.93 | -6.3700 | 4.0300 | 1.94 | 0.66 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 60.49 | 39.82 | 1.4800 | 1.0200 |
| 2014 | 56.59 | 43.41 | 1.6000 | 1.0200 |
| 2015 | 46.47 | 53.36 | 1.8800 | 1.3200 |
| 2016 | 35.17 | 64.83 | 2.2900 | 1.7900 |
| 2017 | 16.99 | 83.01 | 4.6800 | 2.4600 |
| 2018 | 18.16 | 81.84 | 4.5000 | 2.5300 |
| 2019 | 13.30 | 86.70 | 6.5600 | 5.4600 |
| 2020 | 15.22 | 84.71 | 5.7500 | 4.9600 |
| 2021 | 22.14 | 77.91 | 4.2800 | 3.8800 |
| 2022 | 39.34 | 60.66 | 2.4000 | 2.0700 |
| 2023 | 33.71 | 66.29 | 2.8300 | 2.3100 |
| 2024 | 30.61 | 69.39 | 3.2500 | 2.6800 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 352000000.0000 | 19939800.0000 | 36975600.0000 | 1162700.0000 |
| 2014 | 453000000.0000 | 22945300.0000 | 42659500.0000 | 8217100.0000 |
| 2015 | 505000000.0000 | 31275100.0000 | 62498300.0000 | 9603800.0000 |
| 2016 | 724000000.0000 | 62908000.0000 | 113000000.0000 | 9763400.0000 |
| 2017 | 932000000.0000 | 137000000.0000 | 119000000.0000 | 4421200.0000 |
| 2018 | 965000000.0000 | 77962800.0000 | 119000000.0000 | 4188900.0000 |
| 2019 | 1047000000.0000 | 86477500.0000 | 115000000.0000 | 1575700.0000 |
| 2020 | 1081000000.0000 | 79425900.0000 | 120000000.0000 | 239200.0000 |
| 2021 | 1485000000.0000 | 125000000.0000 | 194000000.0000 | 3246500.0000 |
| 2022 | 3262000000.0000 | 184000000.0000 | 356000000.0000 | 9014900.0000 |
| 2023 | 1843000000.0000 | 98687800.0000 | 203000000.0000 | 8740000.0000 |
| 2024 | 1837000000.0000 | 88946900.0000 | 215000000.0000 | 10809000.0000 |